Europe Diabetic Assays Market - Industry Trends and Forecast To 2027

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE DIABETIC ASSAYS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCTS LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.10 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 INCREASING PREVALENCE OF DIABETES

3.1.2 INCREASING GERIATRIC POPULATION

3.1.3 TECHNOLOGICAL ADVANCEMENT

3.1.4 AVAILABILITY OF REIMBURSEMENT

3.1.5 INCREASING DEMAND FOR THE HAND-HELD DIAGNOSTIC DEVICES

3.2 RESTRAINT

3.2.1 PRODUCT RECALL

3.2.2 HIGH COST OF THE ASSAY

3.2.3 IMPLEMENTATION OF EXCISE DUTY BY THE U.S. GOVERNMENT

3.3 OPPORTUNITIES

3.3.1 RISING GOVERNMENT INITIATIVES

3.3.2 STRATEGIC INITIATIVE BY MARKET PLAYERS

3.3.3 RISE IN AWARENESS AMONG THE POPULATION

3.3.4 GROWING HEALTHCARE INFRASTRUCTURE

3.4 CHALLENGES

3.4.1 STRINGENT REGULATION

3.4.2 LACK OF SKILLED PROFESSIONALS

3.4.3 LOW PENETRATION IN DEVELOPING ECONOMIES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 REGULATORY PROCEDURE

7 EUROPE DIABETIC ASSAYS MARKET, BY TYPE

7.1 OVERVIEW

7.2 ASSAYS

7.2.1 DIABETES DIAGNOSTICS GLUCOSE ASSAY

7.2.2 DIABETES DIAGNOSTICS HBA1C ASSAY

7.3 DEVICES

7.3.1 ANALYZERS

7.3.2 SOFTWARE

7.4 CONSUMABLES

7.4.1 TEST STRIPS

7.4.2 REAGENT

7.4.3 OTHERS

8 EUROPE DIABETIC ASSAYS MARKET, BY DISEASE TYPE

8.1 OVERVIEW

8.2 TYPE 2 DIABETES

8.3 TYPE 1 DIABETES

8.4 GESTATIONAL DIABETES

9 EUROPE DIABETIC ASSAYS MARKET, BY DEPLOYMENT

9.1 OVERVIEW

9.2 AUTOMATED

9.3 MANUAL

10 EUROPE DIABETIC ASSAYS MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.3 DIAGNOSTIC LABORATORIES

10.4 CLINICS

10.5 ACADEMIC INSTITUTES

10.6 OTHERS

11 EUROPE DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 DIRECT

11.3 INDIRECT

12 EUROPE DIABETIC ASSAYS MARKET, BY GEOGRAPHY

12.1 EUROPE

12.1.1 GERMANY

12.1.2 FRANCE

12.1.3 ITALY

12.1.4 U.K.

12.1.5 SPAIN

12.1.6 RUSSIA

12.1.7 NETHERLANDS

12.1.8 SWITZERLAND

12.1.9 BELGIUM

12.1.10 TURKEY

12.1.11 REST OF EUROPE

13 EUROPE DIABETIC ASSAYS MARKET, COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: EUROPE

14 COMPANY PROFILE

14.1 BIO-RAD LABORATORIES, INC.

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENT

14.2 ABBOTT

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENT

14.3 SIEMENS HEALTHINEERS AG

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENT

14.4 DANAHER

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 COMPANY SHARE ANALYSIS

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENT

14.5 DIASORIN S.P.A.

14.5.1 COMPANY SNAPSHOT

14.5.2 REVENUE ANALYSIS

14.5.3 COMPANY SHARE ANALYSIS

14.5.4 PRODUCT PORTFOLIO

14.5.5 RECENT DEVELOPMENT

14.6 ABNOVA CORPORATION

14.6.1 COMPANY SNAPSHOT

14.6.2 PRODUCT PORTFOLIO

14.6.3 RECENT DEVELOPMENT

14.7 ALPCO

14.7.1 COMPANY SNAPSHOT

14.7.2 PRODUCT PORTFOLIO

14.7.3 RECENT DEVELOPMENTS

14.8 BIOASSAY SYSTEMS

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENT

14.9 DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.

14.9.1 COMPANY SNAPSHOT

14.9.2 PRODUCT PORTFOLIO

14.9.3 RECENT DEVELOPMENT

14.10 DIAZYME LABORATORIES, INC.

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENTS

14.11 DRG INSTRUMENTS GMBH

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENT

14.12 EKF DIAGNOSTICS HOLDINGS PLC

14.12.1 COMPANY SNAPSHOT

14.12.2 REVENUE ANALYSIS

14.12.3 PRODUCT PORTFOLIO

14.12.4 RECENT DEVELOPMENT

14.13 ETHOS BIOSCIENCES, INC.

14.13.1 COMPANY SNAPSHOT

14.13.2 PRODUCT PORTFOLIO

14.13.3 RECENT DEVELOPMENT

14.14 MEDIPAN GMBH

14.14.1 COMPANY SNAPSHOT

14.14.2 PRODUCT PORTFOLIO

14.14.3 RECENT DEVELOPMENT

14.15 MERCK KGAA

14.15.1 COMPANY SNAPSHOT

14.15.2 REVENUE ANALYSIS

14.15.3 PRODUCT PORTFOLIO

14.15.4 RECENT DEVELOPMENT

14.16 MONOBIND INC.

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT DEVELOPMENT

14.17 ORGENTEC DIAGNOSTIKA GMBH

14.17.1 COMPANY SNAPSHOT

14.17.2 PRODUCT PORTFOLIO

14.17.3 RECENT DEVELOPMENT

14.18 ORTHO CLINICAL DIAGNOSTICS

14.18.1 COMPANY SNAPSHOT

14.18.2 PRODUCT PORTFOLIO

14.18.3 RECENT DEVELOPMENT

14.19 PTS DIAGNOSTICS (A SUBSIDIARY OF SANNUO BIOSENSOR CO., LTD.)

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENT

14.20 TOSOH CORPORATION

14.20.1 COMPANY SNAPSHOT

14.20.2 REVENUE ANALYSIS

14.20.3 PRODUCT PORTFOLIO

14.20.4 RECENT DEVELOPMENT

15 QUESTIONNAIRE

16 RELATED REPORTS

TABLE 1 CANADA REIMBURSEMENT LIMITS FOR TEST STRIPS FOR EACH 365-DAY PERIOD

TABLE 2 IRELAND REIMBURSEMENT FOR TEST STRIPS

TABLE 3 COMPARISON OF NGSP-CERTIFIED A1C POC DEVICES

TABLE 4 MEDICAL DEVICE RECALLS

TABLE 5 BIO-RAD LABORATORIES, INC. (U.S.) DIABETIC ASSAYS PRICES

TABLE 6 PRIVATE-SECTOR R&D INVESTMENT IN MEDICAL DEVICES AND EQUIPMENT ( IN USD MILLION)

TABLE 7 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC

TABLE 8 DIRECT COSTS OF DIABETES (IN USD)

TABLE 9 EUROPE DIABETIC ASSAYS MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 10 EUROPE ASSAYS DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 11 EUROPE ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 12 EUROPE DEVICES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 EUROPE DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 14 EUROPE CONSUMABLES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 15 EUROPE CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 16 EUROPE DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 17 EUROPE TYPE 2 DIABETES DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 EUROPE TYPE 1 DIABETES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 19 EUROPE GESTATIONAL DIABETES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 EUROPE DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 21 EUROPE AUTOMATED IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 22 EUROPE MANUAL IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 23 EUROPE DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 24 EUROPE HOSPITALS IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 25 EUROPE DIAGNOSTIC LABORATORIES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 26 EUROPE CLINICS IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 27 EUROPE ACADEMIC INSTITUTES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 28 EUROPE OTHERS IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 29 EUROPE DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 30 EUROPE DIRECT IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 31 EUROPE INDIRECT IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 32 EUROPE DIABETIC ASSAYS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 33 EUROPE DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 34 EUROPE DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 35 EUROPE ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 36 EUROPE CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 37 EUROPE DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 38 EUROPE DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 39 EUROPE DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 40 EUROPE DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 41 GERMANY DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 42 GERMANY DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 43 GERMANY ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 44 GERMANY CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 45 GERMANY DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 46 GERMANY DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 47 GERMANY DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 48 GERMANY DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 49 FRANCE DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 50 FRANCE DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 51 FRANCE ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 52 FRANCE CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 53 FRANCE DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 54 FRANCE DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 55 FRANCE DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 56 FRANCE DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 57 ITALY DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 58 ITALY DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 59 ITALY ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 60 ITALY CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 61 ITALY DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 62 ITALY DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 63 ITALY DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 64 ITALY DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 65 U.K. DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 66 U.K. DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 67 U.K. ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 68 U.K. CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 69 U.K. DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 70 U.K. DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 71 U.K. DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 72 U.K. DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 73 SPAIN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 74 SPAIN DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 75 SPAIN ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 76 SPAIN CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 77 SPAIN DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 78 SPAIN DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 79 SPAIN DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 80 SPAIN DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 81 RUSSIA DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 82 RUSSIA DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 83 RUSSIA ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 84 RUSSIA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 85 RUSSIA DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 86 RUSSIA DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 87 RUSSIA DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 88 RUSSIA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 89 NETHERLANDS DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 90 NETHERLANDS DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 91 NETHERLANDS ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 92 NETHERLANDS CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 93 NETHERLANDS DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 94 NETHERLANDS DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 95 NETHERLANDS DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 96 NETHERLANDS DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 97 SWITZERLAND DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 98 SWITZERLAND DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 99 SWITZERLAND ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 100 SWITZERLAND CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 101 SWITZERLAND DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 102 SWITZERLAND DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 103 SWITZERLAND DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 104 SWITZERLAND DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 105 BELGIUM DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 106 BELGIUM DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 107 BELGIUM ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 108 BELGIUM CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 109 BELGIUM DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 110 BELGIUM DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 111 BELGIUM DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 112 BELGIUM DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 113 TURKEY DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 114 TURKEY DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 115 TURKEY ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 116 TURKEY CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 117 TURKEY DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 118 TURKEY DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 119 TURKEY DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 120 TURKEY DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 121 REST OF EUROPE DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)